James Hoyes

James Hoyes is the Acting Head of EMD Serono, Inc. in the USA.  Mr. Hoyes is also a member of the Merck Serono Executive Management Board during this ad interim period.

Mr. Hoyes is also the Chief Commercial Officer at EMD Serono, Inc., responsible for business operations in the company’s key therapeutic areas of neurodegenerative diseases, rheumatology, fertility and metabolic endocrinology, as well as Managed Care, Business Intelligence, Health Outcomes, Specialty Pharmacy and Commercial Operations.

In his previous role as Executive Vice President of EMD Serono, Inc., Mr. Hoyes managed the operations of sales, marketing, communications, call center operations, and medical affairs for the Neurology portfolio. He joined EMD Serono in February 2004 as Vice President of Marketing in Neurology.

Prior to joining EMD Serono, Mr. Hoyes gained experience in a variety of commercial roles of increasing responsibilities at Elan, Sanofi-Synthelabo, Sanofi and Sterling Drug. Mr. Hoyes also has extensive experience working in a partnership environment (such as co-promotion and joint venture agreements) with other biopharmaceutical companies such as Pfizer, BMS, UCB and Wyeth.
Mr. Hoyes graduated from Pennsylvania State University with a Bachelor of Science in Biology.